Subscribe   COVID-19 Resource Center twitterLinkedIn YouTube
Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

Video Library

View video lectures on hot topics, challenging cases, and recent advances in psoriasis management presented by key opinion leaders in the field of psoriasis. Presentations and videos are curated from some of the most respected dermatologists in the world and are available at no-cost to clinicians. 

Biologics

Vaccination and Immune Responses in Psoriasis Patients: What We Know and What We Need to Investigate

Biologics, COVID-19 2022

Ulrich Mrowietz, MD | Germany

View

Experiences from the SarsCov-2 Pandemic (and How to Apply Them in the Future)

Biologics, COVID-19 2022

Satveer Mahi, PhD, MRCP | United Kingdom

View

Infections in Psoriasis Patients Treated with Small Molecules, Biologics or the Combination

Biologics 2022

Ricardo Romiti, MD, PhD | Brazil

View

How to Prepare for Another Pandemic

Biologics, COVID-19 2022

Lluís Puig | Satveer Mahil | Ulrich Mrowietz |Ricardo Romiti

View

Real-World Evidence of Systemic Psoriasis Therapies – Part I: Clinical Trials and Observational Studies

Biologics, Other, Take Ten 2022

Alexander Egeberg, MD, PhD, DMSc | Denmark

View

Real-World Evidence of Systemic Psoriasis Therapies – Part II: Drug Survival Studies and Hazard Ratios

Biologics, Other, Take Ten 2022

Alexander Egeberg, MD, PhD, DMSc | Denmark

View

How to Select a Systemic Treatment that Makes Sense

Biologics, Co-morbidities, Personalized care 2022

Craig Leonardi, MD | United States

View

Innovations in Systemic Treatments for Psoriasis

Biologics, New treatments 2022

Andrew Blauvelt, MD, MBA | United States

View

Search Reviews:

Filter by Topic:

Latest news

New IPC Councilor
June 16, 2022
Dr. Claus Johansen joins the group of IPC experts who are working to advance knowledge and enhance the care psoriasis patients around the world.
PsoProtect Registry Data Update
June 15, 2022
PsoProtect, a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data and now includes the first 1,652 cases.
Commentary: Biomarkers of Disease Progression in Psoriasis: Current State-of-the-Art
June 13, 2022
In personalized care for patients, psoriasis biomarkers will be highly relevant. At present, various centers have investigated biomarkers and their clinical significance for psoriasis progression. Read commentary from Andrea Chiricozzi, MD, on three recent publications.
Arcutis Biotherapeutics, Inc. Announced Findings From the Skin Insights: Uncovering Psoriasis Survey
June 02, 2022
Arcutis Biotherapeutics, Inc. shared their finding from the Skin Insights: Uncovering Psoriasis Survey.
More News

Advancing Knowledge. Enhancing Care.

About Us
Strategic Plan
Annual Report
COVID-19 Resource Center
Privacy Statement
News Room
Contact Us
Subscribe 

SUPPORT OUR WORK

IPC's mission is to advance the care of people with psoriasis worldwide, through education, research and advocacy.
 IPC is not in any way engaged in the practice of medicine or acting as a physician or health care professional or provider. The information IPC publishes is not intended as a substitute for the exercise of professional medical judgement by a health care provider following examination of a patient's condition. The ultimate responsibility for a patient's diagnosis or medical treatment rests with the patient's health care provider.

International Psoriasis Council

1034 S. Brentwood Blvd., Suite 600,
St. Louis, MO USA 63117

Tel (972) 861-0503     Fax (214) 242-3391
email info@psoriasiscouncil.org

© 2020 International Psoriasis Council. All Rights Reserved.

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK